Filing Flows › Milestone Scientific (MLSS) › Q2 2026 › vs Q2 2025
Milestone Scientific (MLSS) Q2 2026 vs Q2 2025 (year over year)
Milestone Scientific's revenue rose $518K (+22%) from $2.3M in Q2 2025 to $2.8M in Q2 2026.
Milestone Scientific, Q2 2026: revenue $2.8M (+22% year over year), operating margin -37.4%, net loss $1.1M, operating cash flow −$585K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.8M | $2.3M | $518K | +22% |
| Net loss | $1.1M | $1.5M | −$424K | -29% |
| Costs & expenses | $3.9M | $3.8M | $95K | +2% |
| Operating costs | $3.9M | $3.8M | $95K | +2% |
| Cost of revenue | $931K | $706K | $225K | +32% |
| Research & development | $7K | $52K | −$45K | -87% |
| SG&A | $2.9M | $3.0M | −$85K | -3% |
| Other operating costs | $20K | $19K | $93 | +0.5% |
| Operating cash sources | $1.1M | $1.5M | −$424K | -29% |
| Depreciation & amortization | $20K | $19K | $93 | +0.5% |
| Share-based compensation | $310K | $160K | $150K | +94% |
| Working capital & other | $145K | −$460K | $605K | — |
| Cash used in operations | $585K | $1.8M | −$1.2M | -67% |
| Net loss absorbed | $1.1M | $1.5M | −$424K | -29% |
Questions
How much did Milestone Scientific's revenue grow year over year in Q2 2026?
Milestone Scientific's revenue rose $518K (+22%) from $2.3M in Q2 2025 to $2.8M in Q2 2026.